SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Harvard Medical School has selected Agilent’s 700-MHz Ultra-High Field Nuclear Magnetic Resonance (NMR) spectrometer for biomolecular research applications.
